GS 1720
Alternative Names: GS-1720Latest Information Update: 11 Mar 2024
At a glance
- Originator Gilead Sciences
- Class Antiretrovirals
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I HIV infections